Current Oncology (Feb 2022)

Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (<i>TEMPO</i>) Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot Trial

  • Sylvie D. Lambert,
  • Lindsay R. Duncan,
  • S. Nicole Culos-Reed,
  • Laura Hallward,
  • Celestia S. Higano,
  • Ekaterina Loban,
  • Anne Katz,
  • Manon De Raad,
  • Janet Ellis,
  • Melissa B. Korman,
  • Carly Sears,
  • Cindy Ibberson,
  • Lauren Walker,
  • Eric Belzile,
  • Paramita Saha-Chaudhuri,
  • Helen McTaggart-Cowan,
  • Stuart Peacock

DOI
https://doi.org/10.3390/curroncol29020067
Journal volume & issue
Vol. 29, no. 2
pp. 785 – 804

Abstract

Read online

Background: Prostate cancer is the most common cancer diagnosis among men. Family caregivers (often female spouses) play a key role in ensuring patients’ needs are met, frequently assuming their role with no formal training, which can contribute to a high burden. The purpose of this study was to pilot TEMPO—the first dyadic, Tailored, wEb-based, psychosocial and physical activity self-Management PrOgram for men with prostate cancer and their caregivers. Methods: 49 men with prostate cancer and their caregivers were randomized to TEMPO or usual care. Baseline and follow-up questionnaires were completed to assess feasibility, acceptability, and clinical significance. A priori benchmarks for these outcomes were set. Thirteen exit interviews were conducted to further explore acceptability. Results: Feasibility benchmarks were met with the exception for recruitment with on average 6.1 dyads recruited/month (benchmark: 8 dyads/month). Benchmarks of acceptability focused on attrition (<25%) and system usability, which were met. Using the strict criteria for adherence of 100% of the module viewed and participants spending at least 15 min on the module, 45% of participants were adherent. The clinical significance on anxiety and quality of life was supported for caregivers, and mostly supported for the men with prostate cancer. Conclusion: This pilot trial was successful, with minor modifications needed prior to a large trial.

Keywords